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OBJECTIVES The purpose of this study was to evaluate the feasibility, safety and efficacy of using a
snare-assisted technique to coil occlude the moderate to large size patent ductus arteriosus
(PDA).
BACKGROUND Transcatheter occlusion of small PDAs using Gianturco coils is safe and effective. However,
in larger size PDAs and/or those with short PDA length, the procedure still carries risks of
coil embolization, incomplete occlusion and failure to implant the coil.
METHODS From January 1994 to June 1997, the records of 104 consecutive snare-assisted coil occlusions
of moderate to large PDAs (minimum diameter .2.0 mm) were reviewed. Immediate and
intermediate outcomes including complete and partial occlusion, failure to implant and
complications were analyzed with respect to ductal type and size.
RESULTS Patient age ranged from 0.1 to 70.1 years (median 3.3 years). Minimum PDA diameter
ranged from 2.1 to 6.8 mm (mean 3.0 6 0.9 mm). Angiographic types were A-62, B-13, C-6,
D-14 and E-9. Using the snare-assisted technique, coil placement was successful in 104/104
patients (100%), irrespective of size or angiographic type. Immediate complete closure was
observed in 73/104 (70.2%) and was related to smaller PDA size, but not to angiographic
type. Complete closure was documented in 102/104 (98.1%) at 2- to 16-month follow-up.
Successful closure was unrelated to PDA size or type. Coil embolization to the pulmonary
artery occurred in 3/104 (2.9%) patients and was not related to PDA size or type. The need
for multiple coils was found in 28/104 patients (26.9%), and was related to larger PDA size,
but not to angiographic type.
CONCLUSIONS The snare-assisted delivery technique allows successful occlusion of moderate to large PDAs
up to 6.8 mm, irrespective of angiographic type. This technique permits improved control and
accuracy of coil placement, and facilitates delivery of multiple coils. (J Am Coll Cardiol 1999;
33:1710–8) © 1999 by the American College of Cardiology
Transcatheter occlusion of the small patent ductus arterio-
sus (PDA) using Gianturco coils has been shown to be safe
and efficacious (1–9). It is generally accepted that small
PDAs can be occluded with excellent results, but for both
larger diameter and shorter length PDAs, failure to implant,
coil embolization during delivery and residual shunts remain
problematic (3,4,6,7).
The initial use of a transvenous nitinol snare to “hold” the
coil during its delivery to the PDA was designed to reduce
the risk of inadvertent coil embolization when the minimum
PDA diameter was underestimated, the PDA was asym-
metrically shaped or the vessel was very compliant (8,9).
However, the approach was subsequently found to have
important additional advantages: improved control of the
coil throughout the procedure, the ability to make fine
adjustments in coil position, the ability to test coil stability
before release, and the ability to remove a suboptimally
placed coil without releasing it into the circulation. This
study reports the immediate and intermediate term out-
comes for coil occlusion of moderate to large PDAs
(.2.0 mm) using the snare-assisted technique.
METHODS
The records of 183 consecutive patients who underwent
snare-assisted coil occlusion of a PDA between January
1994 and June 1997 were reviewed. These patients consti-
tute the combined experience of the two authors. During
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this interval, three other patients with a PDA underwent
cardiac catheterization, but did not undergo attempts at coil
occlusion because of an excessively large type C (tubular)
PDA (two with a minimum diameter of 10 mm and 12 mm
and one with an 8-mm diameter and coexisting coarctation
of the aorta). These three patients were referred for surgery.
All patients with a PDA minimum diameter .2.0 mm,
as measured on the lateral projection of an aortic angiogram,
were identified for our study group. The study group was
further divided into three subgroups: group I (minimum
PDA diameter of 2.1 to 3.0 mm), group II (minimum
diameter 3.1 to 4.0 mm) and group III (minimum diameter
.4.0 mm). The patients were also grouped by angiographic
types (A–E) based on Krichenko’s criteria to assess the
impact of ductal type on outcome (10). Immediate and
intermediate follow-up results were analyzed for each group.
The outcomes of the study group were also compared with
those of our patients with minimum PDA size #2.0 mm
(small PDA group).
Coil occlusion technique. Both authors have previously
presented the snare-assisted technique for coil delivery (8,9).
Through experience with the technique, several important
modifications have been made since the original descrip-
tions:
Using a Cardiomarker catheter (USCI, Billerica, Massa-
chusetts) or a Magic guide wire (Medi-tech, Watertown,
Massachusetts) as a measurement reference, the minimum
PDA diameter, aortic ampulla dimension and ductal length
are measured (Fig. 1). A Berenstein catheter (Medi-tech) is
advanced in retrograde fashion through the PDA into the
main pulmonary artery (MPA), and is snared with a 4-F,
10-mm diameter nitinol snare (Microvena Corp., White
Bear Lake, Minnesota) advanced from the femoral vein. A
Gianturco coil (Cook, Bloomington, Indiana) is selected
with a helical diameter 1.6 to 2 times the minimum PDA
diameter and with a length sufficient to form at least three
loops, and is advanced through the Berenstein catheter.
Approximately 1/4 loop of coil is extruded out of the
catheter. The snare is loosened and withdrawn slowly to
“grab” the distal 2 to 3 mm of the extruded coil tip, which
is devoid of Dacron fibers (Fig. 2). Snaring more than this
length risks entangling the snare in the Dacron fibers of the
coil, and may make subsequent coil release more difficult.
The Berenstein–coil–snare unit is adjusted as a single unit
so that only the snare and the extruded coil segment remain
in the MPA. The remaining coil loops are then delivered
into the aortic ampulla (Fig. 3). By placing gentle traction
on the snare, the coil position is adjusted so that only 1/3
loop and no more than one loop is pulled into the MPA
(Fig. 4). This action often results in wedging of coil loops
further into the aortic ampulla, which improves ductal
occlusion and minimizes coil protrusion into aortic flow
(compare coil position relative to tracheal air column in Fig.
3 and 4). By minimizing the amount of coil in the MPA,
the risk of branch pulmonary artery impingement is also
Abbreviations and Acronyms
LPA 5 left pulmonary artery
MPA 5 main pulmonary artery
PDA 5 patent ductus arteriosus
Figure 1. A descending aortogram in lateral projection demon-
strates a type A patent ductus arteriosus (PDA) with a minimum
diameter of 3.1 mm located just anterior to the tracheal air column
(between white arrows). This air column is highlighted in Figures
1 through 6 with white arrows and serves as an important reference
landmark for coil positioning. A catheter with a 10-mm marker is
placed in the main pulmonary artery (MPA) for measurement
references. (AoD 5 descending aorta.)
Figure 2. A 1/4 loop of the coil is extruded out of the Berenstein
catheter. The snare is loosened and withdrawn gently so that it
slides off the catheter onto the “hook” of the loop to snare the coil.
To minimize entanglement with Dacron fibers on the coil, no
more than 2 to 3 mm of the coil tip should be snared. White
arrows 5 tracheal air column.
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minimized. A hand injection of contrast is performed
through the Berenstein catheter at the aortic ampulla before
snare release (Fig. 5). If the coil appears to be in a good
position with no residual shunting, the snare is opened to
release the coil (Fig. 6). If the coil appears to protrude into
the aortic flow, the snare can pull additional coil into the
MPA. If there is residual shunting more than trace to small,
the Berenstein can be manipulated back through the PDA
while the snare is still “holding” the implanted coil to
prevent inadvertent embolization. Once the Berenstein is
safely through the PDA, the initial coil is released, the
Berenstein is resnared and a second coil is delivered in a
similar fashion. The second coil should have a smaller
diameter than the first, so that it can “nest” inside the larger
Figure 3. The snare–coil–Berenstein unit is adjusted so that only
the proximal coil tip is in the main pulmonary artery and the rest
is in the descending aorta. The entire coil is then delivered out of
the Berenstein into the descending aorta, and the coil loops reform
within the aortic ampulla and descending aorta. The tracheal air
column (between white arrows) is critical for proper coil delivery.
Figure 4. The coil position is adjusted by placing gentle traction
on the snare. Note this maneuver results in wedging of the coil into
the conical shaped ampulla for better occlusion. Comparing the
coil position to the tracheal air column in Figure 3, note also the
coil has been pulled more anteriorly by the snare. The first
proximal loop (solid white arrowhead) is oriented parallel to the
segment of the ductus that contains the minimum diameter as it
enters the pulmonary artery. The horizontal alignment of the
proximal coil loop to the ductus increases its occlusive abilities.
The most distal coil loop (open arrowhead) maintains a perpen-
dicular alignment to the ductus inside the aortic ampulla and will
prevent the coil from embolizing through the ductus into the main
pulmonary artery. White arrows 5 tracheal air column.
Figure 5. Once the coil position is optimal, injection of contrast
medium through the Berenstein catheter immediately after coil
implant is useful to assess residual shunting and to confirm coil
position in relationship to the pulmonary artery and aortic ampulla
before snare release. White arrows 5 tracheal air column.
Figure 6. Coil is released from snare. Note only 1/4 coil loop is
used to anchor the coil in the main pulmonary artery side,
minimizing any risk of impingement of left pulmonary artery flow.
White arrows 5 tracheal air column.
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coil where most residual shunts seem to occur. A repeat
right heart sweep is performed to rule out residual left to
right shunt and left pulmonary artery impingement by the
coil. A final descending aortogram is performed 10 to
15 min after coil delivery (Fig. 7). Antibiotics are adminis-
tered (cefazolin 25 mg/kg), and continued for two to three
doses. All study patients received an echocardiogram to
assess residual shunting within 24 h of the procedure.
Statistical analysis. Statistical comparisons of proportions
were analyzed using either a chi-square or Fischer exact test.
A simple t test was used for comparing populations. A
one-way analysis of variance test was used for comparing
multiple populations. Statistical significance was calculated
using an automated statistical software package (SigmaStat
2.0 for Windows 95, Jandel Scientific, San Rafael, Califor-
nia). A p value of 0.05 was chosen for statistical significance
in all cases.
RESULTS
Patient profile. Of 183 consecutive patients reviewed, 104
met the criteria for our study group (PDA diameter
.2.0 mm); 78 patients fell into the small PDA group (PDA
diameter #2.0 mm) (Table 1). One patient, in whom a
Rashkind device was implanted previously, had several small
residual “jets.” As a result, the minimum PDA dimension
could not be measured and the patient was excluded from
the study. The study group had a median age of 3.3 years
(range 0.1 to 70.1 years), a median weight of 15.3 kg (range
3 to 73 kg) and a mean minimum PDA diameter of 3.0 6
0.9 mm (range 2.1 to 6.8 mm). There were 62 patients in
group I (range 2.1 to 3.0 mm, mean 5 2.4 6 0.2), 27
patients in group II (range 3.1 to 4.0 mm, mean 5 3.5 6
0.3) and 15 patients in group III (range 5 4.1 to 6.8 mm,
mean 5 4.7 6 0.7). The distribution of the angiographic
types was type A, 62; type B, 13; type C, 6; type D, 14; and
type E, 9.
Coil implantation. The results are summarized in Table 1.
Using the snare-assisted technique, coil implantation was
successful in 104/104 study group patients (100%), irrespec-
tive of ductal size or type.
Immediate closure. Immediate complete closure was dem-
onstrated in 73/104 (70.2%) by angiography and/or echo-
cardiography within 24 h in the study group. Immediate
complete closure was significantly greater in the small PDA
group (96.2%, p , 0.001) compared with the study group.
Although no statistical difference in immediate complete
closure rate was found between groups I, II or III, the rates
trended downward as PDA size increased: group I, 77.4%
(48/62); group II, 63.0% (17/27), and group III, 53.3%
(8/15). There was no statistical difference in immediate
complete closure rate based on angiographic type (Table 2):
Figure 7. Final descending aortogram to evaluate for residual
shunting. Note the snare-assisted technique in coil delivery has
permitted most of the coil to be placed on the aortic side where it
participates in occlusion.
Table 1. Summary of Results Using Snare-Assisted Technique on Moderate to Large PDAs
Groups (PDA Minimum Diameter)
Total
I
(2.1–3.0 mm)
II
(3.1–4.0 mm)
III
(>4.0 mm)
Mean minimum diameter
(mm)
2.4 6 0.2 3.5 6 0.3 4.7 6 0.7 3.0 6 0.9
n 62 27 15 104
Failure to implant 0 0 0 0
Immediate complete
occlusion
77.4% (48/62) 63.0% (17/27) 53.3% (8/15) 70.2% (73/104)
2–16-mo F/U 98.4% (61/62)* 100% (27/27) 93.3% (14/15)† 98.1% (102/104)
Multiple coils 9.7% (6.62) 40.7% (11.27) 73.3% (11.15) 26.9% (28/104)
Coil embolization 0 3 0 2.9% (3/104)
*Includes one patient who underwent a second catheterization and one additional coil for complete closure of residual shunt.
†Includes two patients who underwent a second catheterization and one additional coil for complete closure of residual shunt.
F/U 5 follow-up; PDA 5 patent ductus arteriosus.
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A, 66.1% (41/62); B, 76.9% (10/13); C, 66.7% (4/6); D,
78.6% (11/14), and E, 77.8% (7/9).
Follow-up closure results. At 2- to 16-month follow-up,
echocardiogram demonstrated complete occlusion in 102/
104 (98.1%). Three of these patients had undergone a
second catheterization to close an audible residual shunt, at
which time total occlusion was achieved using a single coil.
The two remaining patients with a trace residual shunt by
echocardiogram have no audible murmurs. One patient is
only a few months out from the procedure and has not had
a follow-up echocardiogram. The other patient, at 12
months after coil occlusion, is waiting to see if late sponta-
neous closure will occur. One patient was in group I (PDA
diameter 2.7 mm), and one in group III (4.3 mm). Of the
three patients who underwent recatheterization, one was in
group I (2.4 mm), and two were in group III (4.1 mm,
5.0 mm). With respect to angiographic type, two of these
five patients were type A, and three were type B. Late
closure results of the study group (98.1%) are similar to
those of the small PDA group (98.7%) (Table 3).
Use of single or multiple coils. Multiple coils were im-
planted in 26.9% (28/104) of our study group. Two coils
were used in 23 patients, 3 coils in 2 patients and 4 coils in
1 patient with a 6.8-mm PDA. There was a significant
relationship of multiple coil use with increasing PDA size.
In the small PDA group, multiple coils were used in only
2.6% (2/78) (p , 0.001). Group I patients received multiple
coils in only 9.7% (6/62) of procedures (p , 0.03, compared
with the study group as a whole); both group II (40.7%,
11/27; p , 0.02) and group III (73.3%, 11/15; p , 0.001)
patients received multiple coils more frequently than group
I. In the study group, the mean PDA minimum diameter in
which a single coil was implanted was 2.8 6 0.6 mm
compared with 3.8 6 1.1 mm in the patients with a multiple
coil closure (p , 0.001). The largest PDA to have imme-
diate complete closure with a single coil was 4.9 mm in
diameter.
We found no significant relationship between multiple
coil use and angiographic type. However, comparison be-
tween types A and D approached a statistical difference (p 5
0.067).
Coil embolization. There were no systemic embolizations
and 3/104 (2.9%) coil embolizations to the pulmonary
arteries using the snare-assisted technique. There were no
additional embolizations in the small PDA group. All three
coil embolizations occurred in the early part of the author’s
experience. All embolized coils were retrieved with subse-
quent complete occlusion of the PDA. Embolizations were
unrelated to PDA size or angiographic PDA type.
Left pulmonary artery (LPA)/aortic stenosis secondary to
coil placement. At immediate postcatheterization echo,
there was an increase in Doppler flow velocity at the origin
of the LPA (,2.1 m/s) in 4/104 patients, even though no
significant pressure gradient was found during the postcoil
right heart sweep. This increase in velocity resolved in 3/4
patients by the time of the 6-month follow-up. The one
patient with ongoing echo evidence of increased velocity at
the LPA takeoff had a quantitative lung perfusion scan
which revealed 62% of pulmonary flow to the right lung and
38% to the left lung. There was no Doppler evidence of
aortic impingement in any patient.
Coil removal before release for suboptimal placement.
The snare was used to remove 1 to 7 coils in 28/104 (26.9%)
patients before snare release. The indication for coil removal
included: excessive coil loops slipping through the PDA
into the MPA, coil protrusion into LPA or aortic lumen
and inability to free coil from snare in two patients. Within
the study group, there was no statistically significant rela-
tionship of coil removal and increasing PDA size, although
removal tended to occur more often in larger PDAs: 16% of
group I, 29% of group II and 33% of group III. In contrast,
Table 2. Complete Occlusion by PDA Types
PDA Type n Immediate 2–16-mo F/U
A 62 41/62 (66.1%) 61/62 (98.4%)
B 13 10/13 (76.9%) 12/13 (92.3%)
C 6 4/6 (66.7%) 6/6 (100%)
D 14 11/14 (78.6%) 14/14 (100%)
E 9 7/9 (77.8%) 9/9 (100%)
Total 104 73/104 (70.2%) 102/104 (98.1%)
Abbreviations as in Table 1.
Table 3. Comparison of Study Group to Small PDA Group
Study Group Small PDA Group p Value Total Experience
Mean minimum diameter
(mm)
3.0 6 0.9 1.3 6 0.4 , 0.001 2.3 6 1.1
n 104 78 182
Failure to implant 0 0 NS 0
Immediate complete
occlusion
70.2% (73/104) 96.2% (75/78) , 0.001 81.3% (148/182)
2–16-mo F/U 98.1% (102/104) 98.7% (77/78) NS 98.4% (179/182)
Multiple coils 26.9% (28/104) 2.6% (2/78) , 0.001 16.5% (30/182)
Coil embolization 2.9% (3/104) 0 1.6% (3/182)
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only 5% of coils were removed in the small PDA group (p ,
0.02).
There was no statistically discernible relationship be-
tween the need for coil removal and angiographic type: type
A, 32%; type B, 30%; type C, 17%; type D, 16%, and type
E, 11%.
DISCUSSION
Experience with coil occlusion of the PDA has grown
dramatically over the past few years (1–9). A variety of
reported techniques have excellent results in closing small
PDAs. The PDA Coil Registry, representing some 46
institutions, reported a large series of 535 patients with a
median minimum PDA diameter of 2.0 mm. Complete
occlusion was achieved in 75% within 24 h, with a 20%
residual shunt rate and a 5% rate of failure to implant a coil.
There was a significant relationship between size and
success rate for the procedure. The average PDA minimum
diameter in the complete closure group was 1.9 mm, the
diameter for “partial success” was 2.4 mm and the mean
diameter for failure to implant was 2.9 mm. There was an
overall 14.9% coil embolization rate to either the pulmonary
or the systemic circulations. The Registry demonstrated a
significant relationship between failure of coil implantation
and angiographic ductal type B.
More recently, studies from single institutions have
shown an improvement in outcome for larger PDAs. Hijazi
and Geggel reported a series of 33 patients with a mean
minimum PDA diameter of 2.8 mm (4). Using a prograde
(transvenous) approach, complete occlusion was achieved in
91% of patients. However, multiple coils were used in 55%
and left pulmonary artery obstruction was seen in 6% of
patients, who received five coils each. Failure to implant and
coil embolization rates were 6% and 9%, respectively.
Owada et al. recently reported a series of 16 patients with
even larger PDAs (minimum diameter .3.5 mm) (7).
Using primarily larger caliber coils (0.052-in. [0.132 cm]
gauge), they documented complete occlusion in 73% of
patients in whom coils were successfully implanted. How-
ever, multiple coils were used in 36%, and the rates of
implantation failure and coil embolization were 31% and
43%, respectively.
Closure results. Using the snare technique in our study
group of moderate to large PDAs, immediate complete
closure was seen in 70.2%, comparable to the Registry
closure rate, despite a statistically larger mean PDA diam-
eter in our study group (p , 0.05).
With respect to late complete closure at follow-up, the
snare patients compare favorably with a nonrandomly se-
lected subset of the Registry patients (5). Ninety-nine of
104 in our study group (95.2%) had complete closure at last
follow-up without reintervention, in contrast to 339/371
(91%, p 5 0.015) in the Registry, which did not include the
5% of patients in whom there was failure to implant a coil.
Our late complete closure rate increases to 97.8% (178/182)
when the small PDA group patients are included, and
increases further to 98.9% (180/182) when three patients
with a residual shunt underwent repeat catheterization for
an additional coil. This is comparable to data reported by
Shim et al. in which 75 patients received coils for a PDA
(6). Their actuarial analysis estimated complete closure in
94% at 20 months and reintervention in 7% of patients.
However, the mean minimum ductal diameter of their study
group was much smaller (1.6 6 0.8 mm) as compared with
that of our group (3.0 6 0.9 mm).
Coil embolization. Embolization of the coil was signifi-
cantly lower in our series than in the PDA Coil Registry
(2.9% vs. 14.9%, p , 0.001), but was not eliminated
entirely. Our embolization rate drops to 1.6% when analyz-
ing all 182 snare patients.
The three cases of coil embolization that occurred were
due to technical errors early in the authors’ learning curve
and lead to refinements in the technique. In one patient, at
the time of coil release, the snare appeared disengaged from
the coil by fluoroscopy. But radioluscent Dacron fibers were
still adherent to the snare. Since this was not appreciated,
withdrawal of the snare resulted in coil embolization into
the LPA. In subsequent cases, after separation of the snare
and coil, instead of withdrawing the disengaged snare, the
snare delivery catheter is advanced over the snare to the coil
tip. In the event that Dacron fibers remain adherent to the
snare, the coil position is stabilized by the catheter as the
snare is withdrawn into its lumen. Once the snare is
withdrawn a few centimeters, the delivery catheter may be
removed. Snaring only the first 2 to 3 mm of the coil where
there are no Dacron fibers also minimizes this risk.
In the second patient, a coil was implanted but dislodged
during advancement of the Berenstein catheter across a
residual shunt in an attempt to place a second coil. This
complication prompted us to maintain the snare on the first
coil during passage of the Berenstein catheter in subsequent
cases.
In the third patient, insufficient coil was snared. During
an attempt to remove the coil, which was suboptimally
placed, the snare slipped off the coil. Since that event,
sufficient coil length (2 to 3 mm) is snared to result in a
visible “bend” to avoid slippage during traction. However,
excessive tension on the coil should be avoided, since that
may cause a “kink” in the coil resulting in more difficult
release. These three complications occurred only once each,
early in our experience (first 13% of patients).
Multiple coils. The use of multiple coils is preferable to
repeat catheterization for closing residual shunts, though
most authors cite the use of multiple coils as a risk factor for
coil impingement on adjacent structures and for coil embo-
lization (3,6,8). It has been our practice to place additional
coils for anything more than trace residual shunting. How-
ever the need for additional coils, during the initial proce-
dure, may be reduced if the first coil is optimally positioned.
Our study group had an equivalent rate of multiple coil
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use compared to the PDA Coil Registry (27% vs. 26%),
despite our significantly larger mean PDA size. Comparison
of our entire population of 182 patients to the Registry
showed that the snare-assisted closures had a significantly
lower rate of multiple coil use (15% vs. 26%, p 5 0.005).
Coil impingement on adjacent structures. Most authors
screened prospectively for impingement of the coils on
adjacent structures as a result of prior experience with the
Rashkind Occluder (11–15). To date, there has been no
significant problem with aortic arch obstruction secondary
to coil position in any series. Some LPA impingement by
the coil, with either frank stenosis and/or increased flow
rates by Doppler, have been noted in some patients by all
authors. Moore et al. found Doppler evidence of LPA
impingement in 10/29 patients (3). The findings of others
were very similar to our own, with no evidence of LPA
stenosis at catheterization, but mild increased Doppler flow
velocity in a few patients (6,16). Hijazi and Geggel reported
2/31 patients with true LPA stenosis secondary to coil
impingement on the lumen (4).
Patent ductus arteriosus angiographic type. Angio-
graphic type B of Krichenko was cited as a risk factor for
procedural failure in the PDA Coil Registry and in other
series (3,4). Using the snare-assisted technique, we found no
relationship of this angiographic type to procedural failure,
to incomplete closure or to multiple coil use.
Advantages of the snare technique. Use of the nitinol
snare to “anchor” the coil during its delivery and to adjust
coil position after delivery has several theoretical advantages.
1. The snare-assisted technique permits simple coil re-
trieval, rather than embolization, when operator error is
encountered such as underestimation of the minimum
PDA diameter or inaccurate coil positioning. Because
there is a learning curve to PDA occlusions, the snare
may act as a “safety net,” resulting in less anxiety for the
inexperienced operator. If embolization is reduced or
eliminated with the snare technique, the patient is spared
additional sedation and radiation time during coil retrieval.
2. After coil delivery, the snare may be used to adjust
suboptimal coil position. Gentle traction often results in
further wedging of the coil loops into the aortic ampulla.
In those cases when the distal coil loops protrude into the
aortic flow, the coil can be pulled further into the
ampulla/MPA (compare Fig. 3 and 4). This is particu-
larly useful in the more difficult type B ductus where the
aortic ampulla is shallow.
3. By “anchoring” the coil with a snare during delivery, less
coil loop is required on the MPA side. In smaller
children, less coil in the MPA reduces the risk of LPA
impingement. At the same time, more coil left in the
aortic ampulla results in improved occlusion. This may
be the primary mechanism by which our high rate of
success was achieved.
4. Early authors recommended the use of a coil with a
helical diameter twice the minimum ductal diameter
(1–3). Since the snare rather than a coil loop anchors the
coil during its delivery, the snare-assisted delivery allows
attempted closure with smaller coils without risk of
embolization. The advantage of a smaller coil is that the
Dacron fibers of the smaller coils overlap its center better
than those of the larger coils (Fig. 8A). Thus, while the
larger coil may reduce risk of embolization, its occlusive
abilities are less. The PDA Coil Registry first reported a
significant relationship between smaller coil size and
successful complete closure. The larger coils are less
compact (Fig. 8B), and may protrude into the MPA
and/or aorta. We have found that by using the snare
technique, coil helical diameter as small as 1.6 times the
minimum ductal diameter can be used. Traction on the
snare allows testing of coil stability in the ampulla before
release. The new larger gauge coils (0.052 in. [0.132 cm])
are more compact, and initial reports of their use are
promising (7).
Disadvantages of the snare-assisted technique. As with
all techniques, there are some disadvantages to the snare-
assisted approach. Some of the perceived shortcomings of
the technique are real, but should diminish with operator
experience.
1. During snare adjustment of the coil position, excessive
coil loops may be inadvertently pulled into the MPA,
necessitating coil removal. In our series, although 28/104
(27%) patients required removal of a suboptimally posi-
tioned coil, 20 were in the first 50% of the series, and
only three retrievals were required in the last 25% of the
cases. Some of these unstable coils would have been at
risk for embolization if the snare had not been used.
2. Coil release may be difficult for the inexperienced oper-
ator. Release is best achieved by pushing the snare
forward into the LPA rather than withdrawing away
from the coil. As the “snared” coil is oriented with the
open end of the loop facing posteriorly, this maneuver
lessens the risk of coil embolization or inadvertent coil
movement. The recent addition of a torque device to the
snare catheter also facilitates release. Extruding no more
than 1/4 loop of coil and snaring only 2 to 3 mm from the
coil tip, as mentioned earlier, is critical for smooth release.
3. The use of the snare adds an additional $135 to the cost
of the procedure. Based on our results, improved implan-
tation rate, higher rates of complete closure and fewer
coils (and catheters) needed for closure should render the
snare-assisted technique more cost-effective, especially
for larger and/or type B PDAs. If embolization occurs, a
snare will be required anyway.
4. The snare technique has been criticized for increasing
the length and complexity of the procedure. The total
fluoroscopic time needed to snare and release the coil is
no more than 15 min. This is comparable to the average
fluoroscopy times reported in the initial series of Hijazi
and Geggel (24 min) and Moore et al. (12.9 min) (3,4).
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Conclusions. In conclusion, the snare-assisted technique
used for coil occlusion of the moderate to large patent
ductus arteriosus is safe and effective. The use of the snare
eliminates PDA type from consideration as a risk factor for
failure. This technique reduces the risk of coil embolization
during delivery and permits more “accurate” coil position-
ing, reducing the risk of implantation failure, late residual
shunting and coil protrusion into the pulmonary and aortic
flow as well as reducing the need for multiple coils to
achieve complete occlusion. We have not found the snare-
assisted technique to be associated with longer procedural
times or additional radiation exposure. The use of this
technique should be considered for larger PDAs or those
perceived to be at high risk based on morphology.
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